Literature DB >> 9709918

What is the evidence of genetic factors in the etiology of Graves' disease? A brief review.

T H Brix1, K O Kyvik, L Hegedüs.   

Abstract

Graves' disease (GD) is generally thought of as a multifactorial disorder in which genetic susceptibility interacts with environmental and endogenous factors to cause disease. The importance of genetic factors is suggested by the clustering of GD within families and by a higher concordance rate for disease in monozygotic than in dizygotic twins. This has, however, recently been shown to be less pronounced than previously thought. During the last decade much effort has been put into characterization of the genetic background of GD. Until recently, most studies have examined associations between GD and the human leukocyte antigen (HLA) region, but recent advances in molecular techniques have opened the way for whole genome screening. A number of HLA and non-HLA candidate genes have been proposed, but despite several large investigations within multiplex families no major susceptibility genes have been identified. This brief review discusses relevant articles published from 1940 through 1997 regarding the influence of genetic factors in the etiology of GD. Ongoing studies focus on whole genome screening in multiplex families as well as population-based twin studies. However, the possibility of GD being a heterogeneous disease without a single well-defined genotype and phenotype should be left open.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709918     DOI: 10.1089/thy.1998.8.627

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Quantification of the genetic component in multi-factorial autoimmune endocrinopathies.

Authors:  R Buzzetti
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

Review 2.  Relationship between cigarette smoking and Graves' ophthalmopathy.

Authors:  L Hegediüs; T H Brix; P Vestergaard
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

3.  No major genes in autoimmune thyroid diseases: complex segregation and epidemiological studies in a large Tunisian pedigree.

Authors:  Noura Bougacha-Elleuch; Saida Ben Arab; Ahmed Rebai; Mouna Mnif; Abdellatif Maalej; Nadia Charfi; Mohamed Ben Lassouad; Jomaa Jouida; Mohamed Abid; Hammadi Ayadi
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 4.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

5.  Update on the medical treatment of Graves' ophthalmopathy.

Authors:  Gregory J Griepentrog; James A Garrity
Journal:  Int J Gen Med       Date:  2009-12-29

6.  Autoimmune disease in a DFNA6/14/38 family carrying a novel missense mutation in WFS1.

Authors:  Michael S Hildebrand; Jessica L Sorensen; Maren Jensen; William J Kimberling; Richard J H Smith
Journal:  Am J Med Genet A       Date:  2008-09-01       Impact factor: 2.802

Review 7.  Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

Authors:  Francesca Pastore; Antonio Martocchia; Manuela Stefanelli; Pietro Prunas; Stefania Giordano; Lavinia Toussan; Antonio Devito; Paolo Falaschi
Journal:  World J Hepatol       Date:  2016-01-18

8.  Fine mapping of thyroglobulin gene identifies two independent risk loci for Graves' disease in Chinese Han population.

Authors:  Miao Xuan; Shuang-Xia Zhao; Chen-Yan Yan; Jun Yang; Ying Li; Li-Ge Song; Huai-Dong Song; Xiu-Zhen Zhang
Journal:  Ann Transl Med       Date:  2019-09

9.  Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity.

Authors:  Melissa Ardley; Thomas McCorquodale; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Thyroid Res       Date:  2012-06-28

10.  Graves' disease in monozygotic twins - a case report.

Authors:  Christoph A Rüst; Beat Knechtle; Thomas Rosemann
Journal:  BMC Endocr Disord       Date:  2013-05-25       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.